Drug maker to buy rival in Japan for $7.7 billion
The drug maker Sankyo said that it would buy its smaller rival Daiichi Pharmaceutical in a $7.7 billion deal that represents a major steptoward the long-anticipated consolidation of the world's
The drug maker Sankyo said that it would buy its smaller rival Daiichi Pharmaceutical in a $7.7 billion deal that represents a major steptoward the long-anticipated consolidation of the world's